Continence and Potency Following Multi-Layer Perinatal Issue alloGraft

Inclusion Criteria:

Male subjects with at least age of 30 to 65
Primary diagnosis of prostate cancer selected for surgical intervention (Radical Prostatectomy)
Primary diagnosis of organ confined untreated prostate cancer
Planned elective radical prostatectomy with bilateral nerve sparing technique
Negative urinalysis within 30 days prior to date of surgery
Patient has no erectile dysfunction (SHIM Score < 14 ) prior to date of surgery
Patient has the willingness to comply with instruction of the investigator
Patient has the willingness to comply with follow-up surveys
Have ability to provide full written consent.

Exclusion Criteria:

High-risk cancer planned for neoadjuvant therapy, full or partial excision of neurovascular bundles
Is unable to comply with learning and documenting penile rehabilitation, including oral 5-phosphodiesterase inhibitor use, vacuum pump therapy use, and/or injectable medications
Patients with a history of more than two weeks treatment with immuno-suppressants (including systemic corticosteroids), cytotoxic chemotherapy within one month prior to initial screening, or who receive such medications during the screening period, or who are anticipated to require such medications during the course of the study
Patients that have had prior hormonal therapy such as Lupron or oral anti-androgens
Patients with poor urinary control at baseline requiring the use of pads for leakage
Previous history of pelvic radiation
Previous history of simple prostatectomy or transurethral prostate surgery
Patients with obesity defined as BMI > 40 kg/m2
History of open pelvic surgery within 5 years except for hernia repair
Poorly controlled diabetes (A1C >8.5%)
Scheduled at the time of screening to undergo chemotherapy, radiation, hormone therapy, or open surgery during the study period
Any neurologic disorder or psychiatric disorder that might confound postsurgical assessments
Has any condition(s), which seriously compromises the subject's ability to participate in this study, sign consent, or has a known history of poor adherence with medical treatment
In the opinion of the PI, has a history of drug or alcohol abuse within last 12 months
Is allergic to Aminoglycoside antibiotics (such as Gentamicin and/or Streptomycin)
Received administration of an investigational drug within 30 days prior to study, and/or has planned administration of another investigational product or procedure during participation in this study